# Kidney disease among adults on tenofovir-based second-line antiretroviral therapy in Dar es Salaam, Tanzania

**Authors:** Sabina F. Mugusi, Grace A. Shayo, Philip G. Sasi, Lulu S. Fundikira, Eric A. Aris, Christopher R. Sudfeld, Ferdinand M. Mugusi

PMC · DOI: 10.4102/sajhivmed.v26i1.1640 · Southern African Journal of HIV Medicine · 2025-01-31

## TL;DR

This study found that adults on tenofovir-based HIV treatment in Tanzania have a high risk of kidney disease, especially those on atazanavir/ritonavir.

## Contribution

The study identifies ATV/r as a significant predictor of kidney disease in TDF-based second-line ART regimens in a Tanzanian population.

## Key findings

- 22% of patients had low eGFR, with higher rates among those on ATV/r.
- 32.2% of patients showed a triad of renal calcinosis, calculi, and nephritis.
- ATV/r users had smaller kidney volumes and more renal calculi and nephritis compared to LPV/r users.

## Abstract

Kidney disease is a growing non-AIDS-related comorbidity among people living with HIV (PLWH). Tenofovir disoproxil fumarate (TDF) can result in proximal tubulopathy and acute tubular injury, whereas atazanavir/ritonavir (ATV/r) can cause interstitial nephritis and renal stones, both of which can lead to chronic kidney disease.

To examine the relationship between second-line combination antiretroviral therapy (ART) and the risk of kidney disease and morphological changes among PLWH in Dar es Salaam, Tanzania.

A cross-sectional study of adult PLWH receiving TDF-based second-line ART. Socio-demographic and clinical data were gathered, and laboratory tests were conducted to determine the estimated glomerular filtration rate (eGFR). Ultrasonography was performed to visualise the kidneys.

A total of 323 patients were enrolled (67.8% women), with a median age of 44 (interquartile range [IQR]: 39–51) years. Patients were on second-line ART for a median of 49 [IQR: 25–73] months, and 60% received ATV/r. Low eGFR (< 90 mL/min per 1.73 m2) was found in 22% of patients, proportionately higher among patients on ATV/r compared to those on a lopinavir/ritonavir (LPV/r) (P < 0.05). Nearly one-third (32.2%) of patients had a triad of renal calcinosis, renal calculi, and nephritis on ultrasonography. Patients using ATV/r had significantly smaller kidney volumes and greater proportions of renal calculi and nephritis compared to those on LPV/r (P < 0.05).

Adults on second-line ART containing TDF were found to have a high prevalence of renal kidney disease in the Tanzanian context. Predictors of kidney disease were older age, proteinuria, and ATV/r-based regimen as compared to LPV/r.

## Linked entities

- **Chemicals:** tenofovir disoproxil fumarate (PubChem CID 5486830), atazanavir/ritonavir (PubChem CID 25134325), lopinavir/ritonavir (PubChem CID 11979606)
- **Diseases:** kidney disease (MONDO:0001343), chronic kidney disease (MONDO:0005300), proteinuria (MONDO:0003634)

## Full-text entities

- **Diseases:** proteinuria (MESH:D011507), proximal tubulopathy (MESH:C557674), renal calcinosis (MESH:D002114), nephritis (MESH:D009393), renal calculi (MESH:D007669), chronic kidney disease (MESH:D051436), interstitial nephritis (MESH:D009395), AIDS (MESH:D000163), Kidney disease (MESH:D007674), acute tubular injury (MESH:D001930), HIV (MESH:D015658)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11830870/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11830870/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC11830870/full.md

---
Source: https://tomesphere.com/paper/PMC11830870